MRC Technology is committed to ensuring that promising medical research is protected and progressed to benefit patients. We are therefore pleased to announce that we are funding partners in an international technology transfer consortium set up to enable translation of health research into new diagnostics and medicines. The UTILE Project will facilitate partnering and licensing opportunities for research funded under the Seventh Framework Programme (FP7) Health and Societal Challenge 1 of Horizon 2020.

UTILE, a Horizon 2020 funded project, will develop an online marketplace to bring together innovation providers and innovation developers, combining technology push and market pull approaches. It aims to add value to promising research to maximise results. UTILE will also provide recommendations to the European Commission for future research and technology transfer within the health sector.

The international consortium is led by PNO Consultants BV (NL) and includes technology transfer organisations: Ascenion GmbH (DE); ASTP Proton (NL); Bergen Teknologioverforing AS (BTO) (NO); Karolinska Institutet Innovations AB (SE); MRC Technology (UK); Tech Transfer Summit Ltd. (UK); and commercial organisations: Ciaotech Srl (IT); Europroject Ood (BG); Europe Unlimited SA (BE); and Innovation Engineering Srl (IT). The US National Institute of Health (NIH) is also actively involved in the project.